JAMES PATRINELY to Drug Resistance, Neoplasm
This is a "connection" page, showing publications JAMES PATRINELY has written about Drug Resistance, Neoplasm.
Connection Strength
0.068
-
Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study. Lancet Oncol. 2021 06; 22(6):836-847.
Score: 0.034
-
Using Machine Learning Algorithms to Predict Immunotherapy Response in Patients with Advanced Melanoma. Clin Cancer Res. 2021 01 01; 27(1):131-140.
Score: 0.033